openPR Logo
Press release

Scleroderma Diagnostics and Therapeutics Market Analysis and Forecast 2017-2021

04-12-2017 11:09 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Scleroderma Diagnostics and Therapeutics Market Analysis

Scleroderma is an autoimmune disease affecting the skin and other organs of the body. There are two main types of the disease: the localized form (called localized scleroderma, limited scleroderma, or morphea) and the systemic form (called systemic scleroderma, diffuse scleroderma, generalized scleroderma, or systemic sclerosis). Laboratory testing can identify antitopoisomerase or anticentromere antibodies. X-rays and computerized tomography (CT) scans are used to look at bone abnormalities. Thermography can detect differences in skin temperature between the lesion and normal tissue. Ultrasound and magnetic resonance imaging (MRI) can aid soft tissue assessment. There are no treatments for scleroderma itself, but organ system–specific complications are treated and relief of symptoms is often achieved with vasodilators such as calcium channel blockers, alpha blockers, serotonin receptor antagonists, angiotensin II receptor inhibitors, statins, local nitrates or iloprost. Effective treatments are available for those with severe disease, including acute kidney disease, pulmonary hypertension, lung inflammation and gastrointestinal problems.

Browse Scleroderma Diagnostics and Therapeutics Market by Indication (Localized, Systemic), Test Type (Blood Tests, Electrocardiogram and Echocardiogram, Imaging Techniques, Pulmonary Function Tests, Skin Biopsy), Drug Class (Calcium Channel Blockers, Chelating Agents, Corticosteroids, Endothelin Receptor Agonists, Immunosuppressive Agents, PDE-5 Inhibitors, Prostacyclin Analogues, ACE Inhibitors, H2 Blockers, Proton Pump Inhibitors) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/scleroderma-diagnostics-therapeutics-market/

The global scleroderma diagnostics and therapeutics market segmentation is based on indication (localized, systemic), test type (blood tests, electrocardiogram and echocardiogram, imaging techniques, pulmonary function tests, skin biopsy), drug class (calcium channel blockers, chelating agents, corticosteroids, endothelin receptor agonists, immunosuppressive agents, PDE-5 inhibitors, prostacyclin analogues, ACE inhibitors, H2 blockers, proton pump inhibitors).

The global scleroderma diagnostics and therapeutics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global scleroderma diagnostics and therapeutics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global scleroderma diagnostics and therapeutics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global scleroderma diagnostics and therapeutics market and profiled in this report include Actelion Pharmaceuticals, Inc., Boehringer Ingelheim, Bayer AG, Corbus Pharmaceutical Holdings Inc., Cytori Therapeutics, Inc., Cumberland Pharmaceuticals, Inc., F. Hoffmann La Roche Ltd., Gilead Sciences, Inc., Merck KGaA, Pfizer, Inc., and Sanofi.
1. Indication
1.1. Localized
1.2. Systemic

2. Test Type
2.1. Blood Tests
2.2. Electrocardiogram and Echocardiogram
2.3. Imaging Techniques
2.4. Pulmonary Function Tests
2.5. Skin Biopsy

3. Drug Class
3.1. Calcium Channel Blockers
3.2. Chelating Agents
3.3. Corticosteroids
3.4. Endothelin Receptor Agonists
3.5. Immunosuppressive Agents
3.6. PDE-5 Inhibitors
3.7. Prostacyclin Analogues
3.8. Others (ACE Inhibitors, H2 Blockers, Proton Pump Inhibitors, etc.)

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. Actelion Pharmaceuticals, Inc.
5.2. Bayer AG
5.3. Boehringer Ingelheim
5.4. Corbus Pharmaceutical Holdings, Inc.
5.5. Cumberland Pharmaceuticals Inc.
5.6. Cytori Therapeutics, Inc.
5.7. F. Hoffmann La Roche Ltd.
5.8. Gilead Sciences, Inc.
5.9. Merck KGaA
5.10. Pfizer, Inc.
5.11. Sanofi

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/scleroderma-diagnostics-therapeutics-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scleroderma Diagnostics and Therapeutics Market Analysis and Forecast 2017-2021 here

News-ID: 499330 • Views: 235

More Releases from iHealthcareAnalyst, Inc.

Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by
Global Cerebrospinal Fluid Management Market to Reach 1.9 US$ billion by 2023 gr …
According to a new market research report (updated 2018) published by iHealthcareAnalyst, Inc., Cerebrospinal Fluid Management Market – Global CSF Products Analysis and Forecast 2018-2023, the global cerebrospinal fluid management market was valued at US$ 1,045 Million in 2013 and to reach US$ 1.9 billion by 2023, growing at a CAGR of 5.5% from 2018-2023. Visit the Global Cerebrospinal Fluid Management Market – Global Patient Solutions, System Strengthening and End Users

All 5 Releases


More Releases for Rest

Livpure Launches Back Rest Cushion
Livpure Sleep is one the flagship brands of the SAR group. A company with a fast-paced growth in corporate India and a valued legacy, Livpure has swooped the sleeping solutions market and with a wide range of smart and innovative products. Livpure understands consumer’s need for comfort and sleep. Livpure, a manufacturer of water purifiers, air conditioners, air coolers, air purifiers, and other home-focused smart solutions, has jumped into the
Learn Details of Arm/Leg Rest Market Report 2017
Arm/Leg Rest market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Browse Full Report: https://www.reportsandmarkets.com/reports/asia-pacific-arm-leg-rest-market-report-2017-1647384 Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Arm/Leg Rest for these regions, from 2012 to 2022 (forecast), including: China, Japan, South
Agrochemicals Market in Rest of World
ReportsWorldwide has announced the addition of a new report title Rest of World: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “Rest of World: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG)
Rest Room Courtesy Is Still Appreciated
Respecting strangers is common courtesy; at least it should be. Kudos to those who respects others’. Historically, restroom courtesy has been engrained in ethics of social responsibility. After all, since grade school, most people have learned the value of picking up behind themselves, when using public rest rooms. Yet unfortunately, there are still countless people who lack rest room courtesy. As a commercial cleaning and building maintenance service provider, too often, Allen Maintenance
Savvy Rest Is Now GOTS Certified
May 25, 2011, Charlottesville, Virginia -- Savvy Rest, Central Virginia manufacturer of organic mattresses and bedding, is now a GOTS-certified company. GOTS stands for Global Organic Textile Standard, and it means that Savvy Rest’s manufacturing facility has passed the most demanding organic requirements a product or manufacturer can meet. GOTS certification ensures that organic textiles have been responsibly harvested, manufactured and labeled. “While any business can sell products that contain some
Turkish Property Outpacing the Rest
Turkey property is now one of the top choices for private property investors in the UK, overseas property investment consultancy Colordarcy has announced. In explaining possible reasons for the rise of Turkey, the firm cited the countries impressive economic growth and fiscal stability, as well as the dire state of the EU, which has devastated many of Turkey's former biggest competitors. Loxley McKenzie, managing director of the firm said: "Turkey is a